Trial · NCT02203331
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | LNG 40 mcg IVR + Placebo Injection | 52 | |
| Overall Study | STARTED | ATZ 300 mcg / LNG 40 mcg IVR + Placebo Injection | 53 | |
| Overall Study | STARTED | ATZ 600 mcg / LNG 40 mcg IVR + Placebo Injection | 55 | |
| Overall Study | STARTED | ATZ 1050 mcg / LNG 40 mcg IVR + Placebo Injection | 53 | |
| Overall Study | STARTED | Placebo IVR + Leuprorelin Injection | 53 | |
| Overall Study | STARTED | Placebo IVR + Placebo Injection | 53 | |
| Overall Study | Treated | LNG 40 mcg IVR + Placebo Injection | 49 | |
| Overall Study | Treated | ATZ 300 mcg / LNG 40 mcg IVR + Placebo Injection | 50 | |
| Overall Study | Treated | ATZ 600 mcg / LNG 40 mcg IVR + Placebo Injection | 54 | |
| Overall Study | Treated | ATZ 1050 mcg / LNG 40 mcg IVR + Placebo Injection | 49 | |
| Overall Study | Treated | Placebo IVR + Leuprorelin Injection | 50 | |
| Overall Study | Treated | Placebo IVR + Placebo Injection | 53 | |
| Overall Study | COMPLETED | LNG 40 mcg IVR + Placebo Injection | 45 | |
| Overall Study | COMPLETED | ATZ 300 mcg / LNG 40 mcg IVR + Placebo Injection | 39 | |
| Overall Study | COMPLETED | ATZ 600 mcg / LNG 40 mcg IVR + Placebo Injection | 50 | |
| Overall Study | COMPLETED | ATZ 1050 mcg / LNG 40 mcg IVR + Placebo Injection | 46 | |
| Overall Study | COMPLETED | Placebo IVR + Leuprorelin Injection | 46 | |
| Overall Study | COMPLETED | Placebo IVR + Placebo Injection | 46 | |
| Overall Study | NOT COMPLETED | LNG 40 mcg IVR + Placebo Injection | 7 | |
| Overall Study | NOT COMPLETED | ATZ 300 mcg / LNG 40 mcg IVR + Placebo Injection | 14 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02203331/flow